CAPTRUST Financial Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$265K Buy
+2,664
New +$244K ﹤0.01% 2741
2026
Q1
– Sell
-45,107
Closed -$911K – 3019
2025
Q4
$911K Buy
+45,107
New +$1.09M ﹤0.01% 1561
2022
Q2
– Sell
-1,996
Closed -$20K – 4912
2022
Q1
$20K Buy
1,996
+1,196
+150% +$15.3K ﹤0.01% 3375
2021
Q4
$19K Buy
+800
New +$15.6K ﹤0.01% 3298

Other funds holding AEHR

CAPTRUST Financial Advisors's AEHR Position: Q3 2026 in Review

CAPTRUST Financial Advisors opened a new position in Aehr Test Systems (AEHR) in Q3 2026: 2,664 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #2741 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in AEHR as recently as Q4 2025.

CAPTRUST Financial Advisors first reported a position in AEHR in Q4 2021 and has held it in 4 quarters since. The position peaked at $911K in Q4 2025. 300 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • CAPTRUST Financial Advisors held 2,664 shares of Aehr Test Systems worth $265K as of Q3 2026.
  • Aehr Test Systems was a new CAPTRUST Financial Advisors position in Q3 2026.
  • Aehr Test Systems made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #2741 holding.
  • CAPTRUST Financial Advisors first reported a position in Aehr Test Systems in Q4 2021 and has held it in 4 quarters since.
  • CAPTRUST Financial Advisors's Aehr Test Systems position peaked at $911K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.